GSK Calls For Preemption Ruling In Zofran Birth Defect MDL

By Mike Curley · July 19, 2019, 4:08 PM EDT

GlaxoSmithKline has renewed its bid to end multidistrict litigation in Massachusetts federal court over claims it didn't warn customers about alleged birth defects resulting from its anti-nausea medication, saying a recent...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum

Case Information

Case Title

In Re: Zofran (Ondansetron)Products Liability Litigation

Case Number

Court

Massachusetts

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

October 13, 2015

Recent Articles By Mike

July 26, 2024
Judge Allows Emotional Damages In Deaf Patient's Bias Suit
July 16, 2024
3rd Circ. Backs Tossing Over 1K Suits In Merck Vaccine MDL
June 28, 2024
Philips Gets OK For $25M Med Monitoring Deal In CPAP MDL
June 27, 2024
Whole Foods, Hain Want Full 5th Circ. Review Of Baby Food Suit
June 20, 2024
11th Circ. Upholds $2.5M Pelvic Mesh Verdict, Rules Suit Timely
June 18, 2024
COVID Test Maker Can't Shake All Of $30M Faulty Kit Suit
May 31, 2024
Weight Loss Drug Caused Stomach Paralysis, Suit Says
May 22, 2024
NC Panel Revives Retention Claim In Faulty Back Surgery Suit
May 21, 2024
Counties Not 'Persons' In Texas Opioid MDL Appeal
May 16, 2024
NY High Court Blocks Doctor's Hospital Shooting Injury Suit